doi.org/10.1016/s0140-6736(21)00763-7

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

..., Amy J. Sehnert
37
The Lancet88.50
Volume: 397, Issue: 10293, Pages: 2467 - 2475
Published: May 15, 2021
Paper Fields
Paper Details
Title
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
DOI
doi.org/10.1016/s0140-6736(21)00763-7
Published Date
May 15, 2021
Journal
The Lancet
Volume
397
Issue
10293
Pages
2467 - 2475
© 2026 Pluto Labs All rights reserved.